Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Product/Service, Webcast

OncoNano Medicine to Present at The World Molecular Imaging Congress


OncoNano Medicine, Inc. today announced an oral presentation at The World Molecular Imaging Congress 2021 (WMIC) to be held virtually on October 6-9, 2021.

Full details of the presentation are listed below:

TITLE: Fluorescence Image Guided Surgical Resection of Solid Tumors Using the pH-Responsive Micellar Imaging Agent Pegsitacianine: A Summary of an Ongoing Phase 2 Study

PRESENTER: Dr. Jason Newman
DATE: October 8th, 2021
TIME: 10:00 ? 11:30 AM
LOCATION: Virtual

About OncoNano Medicine

OncoNano Medicine is developing a new class of products that utilize principles of molecular cooperativity in their design to exploit pH as a biomarker to diagnose and treat cancer with high specificity. Our product candidates and interventions are designed to help patients across the continuum of cancer care and include solid tumor therapeutics, agents for real-time image-guided surgery and a platform of immune-oncology therapeutics that activate and guide the body's immune system to target cancer.

OncoNano's lead development candidate is pegsitacianine, a novel fluorescent nanoprobe, that is currently under study in Phase 2 clinical trials as a real-time surgical imaging agent for use in multiple cancer surgeries. ONM-501, OncoNano's second development program, is a next generation STING (STimulator of INterferon Genes) agonist that is advancing towards a first in human trial in the first half of 2023. Pegsitacianine and ONM-501 have been supported by grants received from the Cancer Prevention Research Institute of Texas. Learn more at www.OncoNano.com.


These press releases may also interest you

at 06:05
Jumio, the leading provider of AI-powered end-to-end identity verification, eKYC and AML solutions, today announced the launch of an intuitive no-code orchestration layer for its KYX Platform that unifies an entire set of risk and fraud detection...

at 06:05
Merck , known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the European Medicines Agency (EMA) has initiated a rolling review for molnupiravir, an investigational oral antiviral medicine, for the...

at 06:05
Mojenta, the first and only B2B tech marketing agency, announced today it has successfully completed 11 years in business. In that time, Mojenta has serviced nearly 300 telecom carriers, technology service distributors, managed services providers...

at 06:03
DevOps Institute (https://www.devopsinstitute.com/), a global professional association for advancing and certifying the humans of DevOps, today announced an exclusive distributor agreement and strategic partnership with Top Out Human Capital to serve...

at 06:02
Following the successful and well-received Allograft line, Neoss is excited to announce the addition of NeoGenix XPtm this autumn to our existing product portfolio. NeoGenix XPtm is a safe and clinically proven natural bone substitute, that closer...

at 06:01
ADS-TEC Energy GmbH ("ADS-TEC Energy" or "the Company"), a global leader in battery-buffered ultrafast charging technology, and Polar Structure AB ("Polar"), a platform for managing infrastructure related assets, today announced that they have...



News published on 20 september 2021 at 07:05 and distributed by: